UNSPSC 51352413: Ethinyl estradiol/levonorgestrel

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS200. This VA Drug Class (HS200) classifies this compound as belonging to the group CONTRACEPTIVES, SYSTEMIC.

UNSPSC 51352413 Ethinyl estradiol/levonorgestrel, a Commodity code, covers oral contraceptive products containing this hormonal combination supplied to state and local health agencies and employee benefit programs. State and local governments procure these pharmaceuticals through state health and human services departments, cooperative purchasing alliances serving multiple states, and employee benefit plan administrators. The work involves selecting manufacturers, negotiating pricing and supply terms with established wholesalers, and ensuring compliance with FDA manufacturing standards and drug supply chain security requirements. Issuing bodies include state health departments and multistate cooperative purchasing organizations that aggregate demand across participating jurisdictions to leverage volume pricing.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP in January 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products, with awarded vendors effective July 1, 2026, and the Texas Health and Human Services Commission issued an exploratory Request for Information in March 2026 regarding direct-to-manufacturer prescription programs. Recent activity centers in Minnesota and Texas, with the MMCAP procurement spanning participating state and local government facilities across multiple states including Oregon. Vendors responding to these procurements must maintain relationships with authorized wholesalers (AmerisourceBergen, Cardinal Health, and Morris & Dickson in the MMCAP example), hold cGMP certification and DSCSA compliance, and carry comprehensive insurance including $5,000,000 in commercial general liability. Pricing models include fixed pricing, net price formats, and WAC-minus structures, with evaluations weighted heavily on price competitiveness (75 percent in the MMCAP RFP) and compliance with administrative and technical requirements.